A. S. Vestergaard

发表

Aalborg Universitet The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation

Lars, T. Larsen, A. S. Vestergaard, 2017 .

Using Quality Indicators in Health Economic Evaluation to Establish the Value for Money of Quality Improvements: Obstacles and Opportunities

A. S. Vestergaard, 2017 .

The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis

F. Skjøth, L. Ehlers, T. Larsen, 2017, PloS one.

Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study

G. Lip, F. Skjøth, T. Larsen, 2016, Stroke.

A Health Economic Evaluation of Stroke Prevention in Atrial Fibrillation: Guideline Adherence Versus the Observed Treatment Strategy Prior to 2012 in Denmark

L. Ehlers, A. S. Vestergaard, 2015, PharmacoEconomics.

Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial

M. B. Jensen, S. S. Sørensen, L. Ehlers, 2020, BMJ Open.

Cost-effectiveness of treatments for non-osteoarthritic knee pain conditions: A systematic review

M. B. Jensen, M. Rathleff, T. Afzali, 2018, PloS one.